[EN] PROLYL HYDROXYLASE INHIBITORS<br/>[FR] INHIBITEURS DES PROLYL HYDROXYLASES
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2009073497A2
公开(公告)日:2009-06-11
The invention described herein relates to certain quinoxaline-5-carboxamide derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS
申请人:[en]NMD PHARMA A/S
公开号:WO2024121130A1
公开(公告)日:2024-06-13
The present disclosure relates to compounds suitable for treating, ameliorating and/or preventing neuromuscular disorders, including the reversal of drug-induced neuromuscular blockade. The compounds as defined herein can inhibit the CIC-1 ion channel.